METHODS

Subjects:
This study recruited 43 high myopic patients with cataracts and 42 non-myopic patients with cataracts in the Beijing Tongren Hospital, China, from June 2017 to November 2019. All patients included 58 females and 27 males, with an average age of 63.60 ± 10.16 years old (mean ± SD). All patients were relatively healthy without systemic diseases, such as immune diseases, kidney diseases, diabetes. The Institutional Review Board of Beijing Tongren Hospital approved this case-control study. The protocol (TRECKY2017-018) was approved by the Ethics Committee of Beijing Tongren Hospital. This study was registered (clinical trial accession number: ChiCTR1800014657). Written informed consent was obtained from all patients before participation. All procedures adhered to the Declaration of Helsinki and the ARVO statement on human subjects, and were conducted in accordance with the approved research protocol.
The following inclusion criteria were used: patients with age-related cataracts, older than 40 years old, nuclear and cortical cataract, severity of cataract above grade 3 who need cataract surgery, posterior subcapsular patients with cataracts with best-corrected visual acuity (BCVA) lower than 0.3, severe high myopia cataract with axial length greater than or equal to 26 mm and greater than −6 D, and non-high myopia cataract axial length at 21-25 mm and diopter is less than −6 D. Eyes with glaucoma, uveitis, previous trauma, fundus diseases, or diabetes-related eye diseases were excluded from the study by clinical examination and clinical history. The axial length and diopter of high myopic patients with cataracts were 30.41±1.956mm and -18.14±5.716D. The axial length and diopter of non-high myopic patients with cataracts were 23.05±0.891mm and -0.13±1.654D.
Examination: All patients underwent slit-lamp microscopy (Haag Streit, Berne, Switzerland) to determine the type and severity of cataract. At the same time, a non-mydriatic fundus camera (CR-DGI camera; Canon, Tokyo, Japan) was used to check the fundus and optical coherence tomography (OCT; Optovue, Fremont, CA) to check the patients' macular condition. The refractive test was performed by using a computer optometer (Topcon, Tokyo, Japan) for preliminary detection, and then by a professional optometrist for shadow optometry to determine the final refractive power. Axial length was measured with IOLmaster (Carl Zeiss, Jena, Germany).
Aqueous humor collection:
All cataract surgeries were performed by the same surgeon (WXH). Eyelids and surrounding skin were wiped with disinfectant. Samples of aqueous humor (100-200 μl) were aspirated through corneal paracentesis, by inserting a 26-gauge needle into the anterior chamber just before the surgery. Samples were immediately stored at −80 °C until used for proteomic analysis.
G-series human cytokine antibody array 440:
In this study, the G-Series Human Cytokine Antibody Array 440 (product GSH-CAA-440; RayBio; RayBiotech, Norcross, GA) was used for the detection of the cytokines in aqueous humor of high myopic patients with cataracts and non-myopic patients with cataracts in the screening stage.
Four hundred forty cytokines were simultaneously analyzed with an antibody-based protein array. The test was performed following the manufacturer's instructions. Briefly, the cytokine antibody array follows the sandwich immunoassay principle [14] . A unique set of antibodies was immobilized in specific location spots on the surface of a membrane. Array membranes were incubated with samples of aqueous humor from nine high myopic patients with cataracts (Group 1) and eight non-myopic patients with cataracts (Group 2). As the volume of aqueous humor in one eye cannot meet the requirement for cytokine chip measurement, the aqueous humors in two eyes of the same person were mixed for measurement in this study. Antibodies captured the corresponding cytokines, and then a cocktail of biotinylated antibodies was used to detect bound cytokines. In this study, fluorescent dye-conjugated streptavidin (Cy3 equivalent) was used for the visualization of the signals, and the InnoScan 300 Microarray Scanner (Innopsys, Carbonne, France) was used for the detection of signals. Densitometric analysis of each spot was then performed using a Q-Analyzer program.
Quantibody custom array:
To reduce errors and improve accuracy, a quantitative protein detection chip RayBio Quantibody Custom Array (product QAH-CUST; RayBio; RayBiotech, Norcross, GA) was used for the verification of the cytokines of interest in the confirmatory stage. Concentrations of the 11 screened cytokines in the aqueous humor sample obtained from 34 eyes of high myopic patients with cataracts (Group 3) and 34 eyes of non-myopic patients with cataracts (Group 4) were determined using a human 11-plex assay. Antibodies captured corresponding cytokines, and then a cocktail of biotinylated antibodies was used to detect bound cytokines. The test method for the signals was same as that for the G-Series Human Cytokine Antibody Array 440.
Statistical analysis: All data are shown as mean ± standard deviation. A chi-square test was used to examine differences in categorical variables. One-way analysis of variance (ANOVA) followed by Tukey's test was used to detect statistically significant differences in quantitative variables. Student t test was used to detect differences between two groups. A p value of less than 0.05 was considered statistically significant. As there were 440 different comparisons, p = 0.000114 (i.e., p = 0.05 / 440) was considered statistically significant after Bonferroni correction. All analyses were performed using SPSS software version 20.0 (SPSS, Inc., IBM, New York, NY). Table 1 . There were no statistical differences among the four groups in age (F = 1.932, p = 0.131), gender (p = 0.397), and eye(s) (p = 0.804; all p>0.05, ANOVA and Tukey's test for age; chi-square tests for gender and eye(s)).
RESULTS
Demographic data: Demographic characteristics of patients are presented in
G-Series Human Cytokine Antibody Array 440:
In the test group, the G-Series Human Cytokine Antibody Array 440 was used to determine the expression levels of 440 cytokines in the aqueous humor of high myopic patients with cataracts and non-myopic patients with cataracts. Marked changes in the aqueous humor cytokines were found in the high myopic patients with cataracts compared with the non-myopic patients with cataracts (Appendix 1). After Bonferroni correction (p<0.000114, Student t test with Bonferroni correction), the expression levels of decorin, RANK, ANG-1, CXCL16, bIG-H3, IGFBP-2, and IL-17B in the aqueous humor of the high myopic patients with cataracts were much higher than those in the aqueous humor of the non-myopic patients with cataracts, and the expression levels of GITR, PDGF Rb, and IL-9 were much lower in the aqueous humor of the high myopic patients with cataracts compared with the aqueous humor of the non-myopic patients with cataracts ( Table 2) . MMP-2 has been shown in previous studies to be associated with high myopia. MMP-2 is elevated in high myopic eyes and can be used as a positive control. Although the p value for MMP-2 was not lower than 0.000114 after Bonferroni correction in this study, the expression of MMP-2 was still increased in the aqueous humor of the high myopic eyes, and there were differences between the two groups. The differences in the fluorescence of these cytokines in the aqueous humor are shown in Figure 1 . Table 3 shows that the expression levels of ANG-1 and MMP-2 had a statistically significant difference in two groups (all p<0.05). The differences in the fluorescence of ANG-1 and MMP-2 are shown in Figure 2 . 
DISCUSSION
In this study, 440 aqueous humor cytokines were detected in patients with high myopia with cataracts and non-myopic patients with cataracts. It was confirmed that the MMP-2 factor in the aqueous humor of patients with high myopia increased significantly, and many distinct aqueous humor cytokines were found in the screening stage. Through further verification, it was found that ANG-1 was elevated in the aqueous humor of high myopic patients with cataracts.
MMPs play an important role in the formation of prolonged axial length in high myopia. Ding et al. found that the mRNA and protein expression levels of MMP-2 are significantly increased in lens-induced myopic eyes compared with normal eyes in guinea pigs [15] . Li et al. also found that the protein expression of MMP-2 is significantly higher in the scleral fibroblasts of lens-induced myopic eyes in vivo [16] . Liu et al. suggested that overexpression of MMP-2 mediated by the IGF-1/STAT3 pathway in sclera accelerates the elongation of axial length in myopic eyes [17] . The level of MMP-2 in the vitreous body was also higher in high myopic patients than in non-myopic patients [18] . In addition, the MMP-2 level in the aqueous humor of high myopic patients was significantly increased [19] [20] [21] , which was consistent with the present study results at the screening and confirmatory stages.
Several studies confirmed that the level of cytokines in aqueous humor changes markedly in ocular diseases, including high myopia [22] [23] [24] . Duan et al. found that, compared with non-myopic eyes, the total protein concentration in aqueous humor is significantly higher in eyes with high myopia, and the protein composition was also different between myopic and non-myopic eyes [7] . Kim et al. found that the oxidative stress in aqueous humor is lower in high myopic eyes, which is negatively correlated with elongated axial length [25] . Multiple studies also confirmed that the TGF-β2 concentration in aqueous humor is higher in high myopic eyes, and TGF-βRII expression is elevated in lens epithelial cells (LECs) simultaneously [2, 26] . In addition, high myopia is considered an inflammation-related disease, and highly myopic eyes are believed to have an inflammatory internal microenvironment, which may lead to several inflammation-related complications. Zhu et al. revealed a significant difference in IL-1ra and MCP-1 expression between high myopia and non-myopic eyes, which indicates Table 3 a proinflammatory status in the anterior chamber of cataract eyes with high myopia [13] . Other studies also disclosed different levels of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in high myopic and non-myopic eyes [27, 28] . However, due to the low expression level of cytokines in aqueous humor, a large number of cytokines cannot be detected simultaneously given the limited technical equipment and detection conditions [13] . In this study, 440 cytokines in aqueous humor could be detected at the same time, which can better show the expression of cytokines in aqueous humor of high myopic eyes.
. The expression levels of cytokines marked changes in high myopic patients with cataracts and non-myopic patients with cataracts by Quantibody Custom Array.
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Over the past few years, with the development of detection technology, simultaneous detection of multiple cytokines in limited samples became feasible, and the accuracy of detection is consistently improving. In the present study, the expression of MMP-2 in the aqueous humor of high myopic patients with cataracts was increased. At the same time, this study screened out new cytokines related to eyes in high myopic patients with cataracts, including decorin, bIG-H3, and ANG-1. The decorin gene has been found to be an antioncogene with the ability to inhibit the growth or metastasis of solid tumors [29] . Moreover, the decorin gene is considered to be the "most likely" candidate gene for high myopia [30] . Decorin is detected in human sclera which may contribute to scleral disorders, such as high myopia [31] . However, Chen et al. found that a decorin gene polymorphism has no significant correlation with high myopia [32] . At the same time, Yip et al. also indicated that proteoglycan genes are not associated with high myopia in these subjects with single nucleotide polymorphisms, and therefore, they may be controversial in the genetic predisposition to high myopia [33] . The RGD sequence in bIG-H3 protein acts as a recognition site for the interaction between avβ3 and its ligand, and becomes a powerful competitive antagonist for the binding between extracellular matrix and cell integrin. Thus, it can inhibit the formation of new blood vessels and vessel walls [34] . Mutations in the bIG-H3 gene result in amyloid deposition and visual impairment. Joseph et al. revealed that the expression of the bIG-H3 protein in the stroma is reduced compared with that in the normal cornea, but the specific mechanism and pathway are not clear [35] . Therefore, bIG-H3 may not be significantly associated with high myopia. These results were the same as in the present study.
However, in the confirmatory stage in the present study, only MMP-2 and ANG-1 exhibited statistically a significant difference and were consistent with the results in the screening stage. ANG-1 is a critical factor for blood vessel stabilization after the formation of a nascent parent endothelial cells (ECs) tube. ANG-1 induces vessel stabilization by inhibiting endothelial permeability and stimulating EC-dependent release of cytokines, including TGFβ and PDGF-BB, which result in recruitment of pericytes to the nascent vessel. ANG-1-mediated recruitment of pericytes is enhanced by VEGF, which stimulates MMP-1 activity [36] . Wu et al. found increased plasma ANG-2 and MMP-2 levels but not ANG-1 levels in patients with coronary heart disease (CHD), revealing a weak correlation between ANG-1 with MMP-2 and a strong correlation between ANG-2 and MMP-2 in patients with CHD, which indicates the involvement of ANG-2 in atherosclerosis, and its interaction with MMP-2 [37] . Loukovaara et al. found a significant correlation between intravitreal concentrations of ANG-2 with MMP-9, VEGF, erythropoietin (EPO), and TGFβ1 levels in diabetic eyes undergoing vitrectomy. Thus, these cytokines could promote retinal angiogenesis synergistically [38] . In the present study, the expression of ANG-1 was higher in the aqueous humor of highly myopic patients with cataracts, which has not been reported by previous studies. However, whether ANG-1 is involved in the formation of high myopia remains to be studied further.
In this study, as the Quantibody Human Cytokine Antibody Array 440 is expensive, the number of screening samples was relatively small. Future studies should collect more samples and expand the sample volume to further verify the relationship between these cytokines and the pathogenesis of high myopia.
In summary, numerous cytokines in aqueous humor were detected in high myopic patients with cataracts and nonmyopic patients with cataracts, and the study confirmed that the MMP-2 level in the aqueous humor of patients with high myopia was significantly increased. Further verification also revealed elevation of ANG-1 in the aqueous humor of high myopic patients with cataracts, which suggests ANG-1 may be related to the pathogenesis of high myopia.
APPENDIX 1. THE EXPRESSION LEVELS OF 440 CYTOKINES IN HIGH MYOPIC CATARACT PATIENTS AND NON-MYOPIC PATIENTS BY HUMAN CYTOKINE ANTIBODY ARRAY 440.
To access the data, click or select the words "Appendix 1." 
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